ISET Publications in Oncology
Ntzifa, A., et al. Comprehensive Liquid Biopsy Analysis for Monitoring NSCLC Patients under Second-Line Osimertinib Treatment Front Oncol. 2024 Oct 21;14:1435537. DOI: https://doi.org/10.3389/fonc.2024.1435537
DOWNLOAD »
Romeliotou, A., et al. Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients Cancers 2023, 15, 171. DOI: https://doi.org/10.3390/cancers15010171
DOWNLOAD »
Pantazaka, E., et al. PD-L1/pS6 in Circulating Tumor Cells (CTCs) during Osimertinib Treatment in Patients with Non-Small Cell Lung Cancer (NSCLC) Biomedicines 2022,
10(8), 1893. DOI: https://doi.org/10.3390/biomedicines10081893
DOWNLOAD »
Kallergi, G. et al. Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy.
Cancers 2022, 14(6), 1574 DOI: https://doi.org/10.3390/cancers14061574
DOWNLOAD »
Katsarou S.D. et al. Detyrosinated α-Tubulin, Vimentin and PD-L1 in Circulating Tumor Cells (CTCs) Isolated from Non-Small Cell Lung Cancer (NSCLC) Patients.
J. Pers. Med. 2022, 12(2), 154. DOI: https://doi.org/10.3390/jpm12020154
DOWNLOAD »
Fina E. et al. Subpopulations of Circulating Cells with Morphological Features of Malignancy Are Preoperatively Detected and
Have Differential Prognostic Significance in Non-Small Cell Lung Cancer.
Cancers 2021, 13(17), 4488. DOI: https://doi.org/10.3390/cancers13174488
DOWNLOAD »
Ilie M. et al. Prospective multi-center validation of the detection of ALK rearrangements of circulating tumor cells for non invasive
longitudinal management of patients with advanced non-small cell lung cancer.
Journal of Thoracic Oncology (2021), DOI: https://doi.org/10.1016/j.jtho.2021.01.1617
DOWNLOAD »
Tamminga M. et al. Detection of Circulating Tumor Cells in the diagnostic leukapheresis product of Non-Small-Cell
Lung Cancer Patients Comparing CellSearch® and ISET.
Cancers 2020, 12(4), 896;; DOI: https://doi.org/10.3390/cancers12040896.
DOWNLOAD »
Castello A. et al. Circulating Tumor Cells and metabolic parameters in NSCLC patients treated with checkpoint inhibitors.
Cancers 2020, 12(2), 487; DOI: https://doi.org/10.3390/cancers12020487
DOWNLOAD »
Monterisi S. et al. Preliminary data on circulating tumor cells in metastatic NSCLC patients candidate to immunotherapy.
Am J Nucl Med Mol Imaging 2019;9(6):282-295 DOI: 10.1158/1078-0432.CCR-19-1176 .
DOWNLOAD »
Pailler E. et al. Acquired resistance mutations to ALK inhibitors identified by Single Circulating Tumor Cell sequencing in ALK-rearranged Non–Small-Cell Lung Cancer.
DOWNLOAD »
Kotsakis A. et al. CD8+ PD-1+ T-cells and PD-L1+ circulating tumor cells in chemotherapy-naïve non-small cell lung cancer: towards their clinical relevance?
Therapeutic advances in medical oncology 11, 1758835919853193 (2019).
DOWNLOAD »
Guibert N. et al. PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab.
Lung cancer (Amsterdam, Netherlands) 120, 108-112 (2018).
DOWNLOAD »
Diaz M. et al. Circulating tumor cells a marker of poor prognosis in metastatic lung cancer: a pilot study.
Applied Cancer Research. 38, 38:8 (2018)
DOWNLOAD »
Kallergi G. et al. Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer.
Therapeutic advances in medical oncology 10, 1758834017750121 (2018).
DOWNLOAD »
Leroy S. et al. Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France.
BMJ open 7, e018884 (2017).
Ilie M. et al. Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small cell lung cancer.
Ann Oncol 29, 193-199 (2018).
DOWNLOAD »
Pailler E. et al. Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK-Rearranged Non-Small Cell Lung Cancer Patients.
Cancer Res 77, 2222-2230 (2017).
DOWNLOAD »
Ilie M. et al. Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients. Oncotarget 8, 26112-26121 (2017).
DOWNLOAD »
Williamson S.C. et al. Vasculogenic mimicry in small cell lung cancer.
Nature communications 7, 13322 (2016).
DOWNLOAD »
Morrow C.J. et al. Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.
Ann Oncol 27, 1155-1160 (2016).
DOWNLOAD »
Pailler E. et al. High level of chromosomal instability in circulating tumor cells of ROS1-Rearranged non-small-cell lung cancer.
Ann Oncol 26, 1408-1415 (2015).
DOWNLOAD »
Ilie M. et al. “Sentinel” circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease.
PLoS One 9, e111597 (2014).
DOWNLOAD »
Faugeroux V. et al. Clinical utility of circulating tumor cells in ALK-positive non-small-cell lung cancer.
Frontiers in oncology 4, 281 (2014).
DOWNLOAD »
Chinen L.T. et al. Cytokeratin-based CTC counting unrelated to clinical follow-up.
J Thorac Dis 5, 593-599 (2013).
DOWNLOAD »
Marchesi V. Lung Cancer: ALK status of NSCLC reflected in CTCs.
Nat Rev Clin Oncol 10, 366 (2013).
DOWNLOAD »
Pailler E. et al. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non–small-cell lung cancer.
J Clin Oncol 31, 2273-2281 (2013).
DOWNLOAD »
Ilie M. et al. ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.
Ann Oncol 23, 2907-2913 (2012).
DOWNLOAD »
Costa D.B. Identification of somatic genomic alterations in circulating tumors cells: another step forward in non-small-cell lung cancer?
J Clin Oncol 31, 2236-2239 (2013).
DOWNLOAD »
Hofman V. et al. Morphological analysis of circulating tumor cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumor cell (ISET) method.
Cytopathology 23, 30-38 (2012).
DOWNLOAD »
Hou J.M. et al. Clinical significance and molecular characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in patients with small-cell lung cancer.
J Clin Oncol 30, 525-532 (2012).
DOWNLOAD
Krebs M.G. et al. Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches.
J Thorac Oncol 7, 306-315 (2012).
DOWNLOAD »
Lecharpentier A. et al. Detection of circulating tumor cells with a hybrid (i.e. epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer.
Br J Cancer 105, 1338-1341 (2011).
DOWNLOAD »
Hofman V. et al. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small cell lung carcinoma: Comparison of the efficacy of the CellSearch AssayTM and the isolation by size of epithelial tumor cell method.
Int J Cancer 129, 1651-1660 (2011).
DOWNLOAD »
Hofman V. et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker.
Clin Cancer Res 17, 827-835 (2011).
DOWNLOAD »
Hofman V. et al. Cytopathologic Detection of Circulating Tumor Cells Using the Isolation by Size of Epithelial Tumor Cell Method.
Am J Clin Pathol 135, 146-156 (2011).
DOWNLOAD »
Hou J.M. et al. Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer.
Am J Pathol 178, 989-996 (2011).
DOWNLOAD »
Guedes de Castro D. et al. Heterogeneity of HER2 Expression in Circulating Tumor Cells of Patients with Breast Cancer Brain Metastases and Impact on Brain Disease Control.
Cancers 2022, 14, 3101. https://doi.org/10.3390/cancers14133101
DOWNLOAD »
Kallergi G. et al. Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements. Breast cancer research : BCR 20, 67 (2018).
DOWNLOAD »
Ried K. et al. Screening for Circulating Tumour Cells Allows Early Detection of Cancer and Monitoring of Treatment Effectiveness: An Observational Study. Asian Pacific journal of cancer prevention : APJCP 18, 2275-2285 (2017).
DOWNLOAD »
Kallergi G. et al. Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs). Cell PhysiolBiochem 40, 411-419 (2016).
DOWNLOAD »
LeBleu V.S. et al. PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol 16, 992-1003, 1001-1015 (2014).
Pinzani P. et al. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. Hum Pathol 37, 711-718 (2006).
DOWNLOAD »
Morris K.L. et al. Circulating biomarkers in hepatocellular carcinoma. Cancer Chemother Pharmacol 74, 323-332 (2014).
DOWNLOAD »
Vona G. et al. Impact of cytomorphological and molecular characterization of circulating tumor cells in patients with Primary Liver Cancer. Hepatology 39, 792-797 (2004).
DOWNLOAD »
Vona G. et al. ISET, Isolation by Size of Epithelial Tumor cells: a new method for isolation, immuno-morphological and molecular characterization of circulating tumor cells. Am J Pathol 156, 57-63 (2000).
DOWNLOAD »
Roumeliotou, A. et al. Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients. Cells 2024, 13(9), 782; DOI: https://doi.org/10.3390/cells13090782
DOWNLOAD »
Garrido Castillo, L.N. et al. Polyploid giant cancer cells are frequently found in the urine of prostate cancer patients. Cancers 2023, 15(13), 3366;. DOI: https://doi.org/10.3390/life12020165
DOWNLOAD »
Garrido Castillo, L.N. et al. Predictive Value of Circulating Tumor Cells Detected by ISET® in Patients with Non-Metastatic Prostate Cancer Undergoing Radical Prostatectomy. Life 2022, 12, 165. DOI: https://doi.org/10.3390/life12020165
DOWNLOAD »
Ried K. et al. New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers.
Front. Oncol., 23 April 2020. DOI: https://doi.org/10.3389/fonc.2020.00582
DOWNLOAD »
Faugeroux V. et al. An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer. European urology oncology (2019).
DOWNLOAD »
Van Der Toom E. et al. Analogous detection of circulating tumor cells using the AccuCyte®—CyteFinder® system and ISET system in patients with locally advanced and metastatic prostate cancer. The Prostate 78, 300-307 (2018).
DOWNLOAD »
Massard C. et al. Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castrationresistant prostate cancer: a report from the PETRUS prospective study. Oncotarget 7, 55069-55082 (2016).
DOWNLOAD »
Cummings J. et al. Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells. BMC Cancer 14, 226 (2014).
DOWNLOAD »
Carreta Ruano A.P. et al. Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma
International Journal of Molecular Sciences 2022, 23, 14687. DOI: https://doi.org/10.3390/ijms232314687
DOWNLOAD »
Corassa M. et al. Circulating tumor cells as a new and additional approach to follow-up patients with serous low-grade ovarian adenocarcinoma – a case report and review of the literature. Applied Cancer Research 37, 12 (2017).
DOWNLOAD »
Lelièvre L. et al. Effect of laparoscopy versus laparotomy on circulating tumor cells using isolation by size of epithelial tumor cells. Int J Gynecol Cancer 14, 229-233 (2004).
DOWNLOAD »
Martel A. et al. Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice. Int.
J. Mol. Sci. 2023, 24, 11075. DOI: https://doi.org/10.3390/ijms241311075
DOWNLOAD »
Long E. et al. High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness. Cancer Med 5, 1022-1030 (2016).
DOWNLOAD »
Mazzini C. et al. Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method. Cancers (Basel) 6, 323-332 (2014).
DOWNLOAD »
Hofman V. et al. Usefulness of Immunocytochemistry for the detection of the BRAFV600E mutation in Circulating Tumor Cells from Metastatic Melanoma Patients. J Invest Dermatol 133, 1378-1381 (2013).
DOWNLOAD »
Khoja L. et al. Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma. Melanoma Res 24, 40-46 (2014).
DOWNLOAD »
De Giorgi V. et al. Application of a filtration and isolation-by-size technique for the detection of criculating tumor cells in cutaneous melanoma. J Invest Dermatol 130, 2440-2447 (2010).
DOWNLOAD »
De Giorgi V. et al. Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis. Arch Dermatol 146, 1120-1124 (2010).
DOWNLOAD »
Pinzani P. et al. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression. Melanoma Res 20, 303-310 (2010).
DOWNLOAD »
Javed, Ammar A. et al. A Delay in Adjuvant Therapy is Associated with Worse Prognosis only in Patients with Transitional Circulating Tumor Cells Following Resection of Pancreatic Ductal Adenocarcinoma. Annals of Surgery, 2022, Doi: 10.1097 https://doi.org/10.1097/SLA.0000000000005710
DOWNLOAD »
Tarazona JGR, et al. Mir-203a-3p And Mmp-2 Proteins Are Highly Expressed In Circulating Tumor Cells From Patients With Pancreatic
Carcinoma.
Arquivos Brasileiros de Cirurgia Digestiva (Brazilian archives of digestive surgery) : ABCD Arq Bras Cir Dig 2021;34(4):e1628. DOI: https://doi.org/10.1590/0102-672020210002e1628
DOWNLOAD »
Yin L. et al. Improved assessment of response status in patients with pancreatic cancer treated with neoadjuvant therapy using somatic mutations and liquid biopsy analysis.
Clin Cancer Res. Published OnlineFirst on October 20, 2020; doi: 10.1158/1078-0432.CCR-20-1746
DOWNLOAD »
Yu J. et al. Pancreatic circulating tumor cell detection by targeted single-cell next-generation sequencing.
Cancer Letters 493 (2020) 245–253
DOWNLOAD »
Gasparini-Junior J.L. et al. Evaluating MMP-2 and TGFβ-RI expression in circulating tumor cells of pancreatic cancer patients and their correlation with clinical evolution.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery 32, e1433 (2019).
DOWNLOAD »
Poruk K.E. et al. Circulating Epithelial Cells in Intraductal Papillary Mucinous Neoplasms and Cystic Pancreatic Lesions. Pancreas 46, 943-947 (2017).
DOWNLOAD »
Poruk K.E. et al. Circulating Tumor Cells Expressing Markers of Tumor Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 23, 2681-2690 (2017).
DOWNLOAD »
Poruk K.E. et al. Circulating Tumor Cells Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma. Annals of surgery 264, 1073-1081 (2016).
DOWNLOAD »
Khoja L. et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer 106, 508-516 (2012).
DOWNLOAD »
Braun A.C. et al. EGFR expression in circulating tumor cells from high-grade Metastatic Sarcomas. Cancer biology & therapy 19, 454-460 (2018).
DOWNLOAD »
Chinen L.T. et al. Isolation, detection and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion. Onco Targets Ther 7, 1609-1617 (2014).
DOWNLOAD »
Carreta Ruano A.P., et al. HPV virus and biomarkers of resistance to chemoradiation in circulating tumor cells from patients with squamous cell carcinoma of the anus. Pathology – Research and Practice 243 (2023). DOI: https://doi.org/10.1016/j.prp.2023.154327
Silva V.S et al. Molecular and Dynamic Evaluation of Proteins Related to Resistance to Neoadjuvant Treatment with Chemoradiotherapy in Circulating Tumor Cells of Patients with Locally Advanced Rectal Cancer. Cells 2021, 10(6), 1539. DOI: https://doi.org/10.3390/cells10061539
Silva V.S et al. Baseline and Kinetic Circulating Tumor Cell Counts Are Prognostic Factors in a Prospective Study of Metastatic Colorectal Cancer. Diagnostics 2021, 11(3), 502. DOI: https://doi.org/10.3390/diagnostics11030502
Abdallah E. A. et al. A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer. Translational Oncology 14 (2021) 100932.
Troncarelli Flores B.C. et al. Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients. Cells 8 (2019).
Messaritakis I. et al. Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer. Cancer Chemother Pharmacol 82, 767-775 (2018).
Matikas A. et al. Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer. Translational oncology 10, 693-698 (2017).
Souza e Silva V. et al. Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells. Onco Targets Ther 9, 7503-7513 (2016).
Abdallah E.A. et al. MRP1 expression in CTCs confers resistance to irinotecan-based treatment in metastatic colorectal cancer. Int J Cancer 139, 890-898 (2016).
Buim M.E. et al. Detection of KRAS mutation in circulating tumor cells from patients with metastatic colorectal cancer. Cancer Biology & Therapy 16:9, 1289-1295 (2015)
Abdallah E.A. et al. Thymidylate synthase expression in circulating tumor cells: a new tool to predict 5-Fluorouacil resistance in metastatic colorectal cancer patients. Int J Cancer 137, 1397-1405 (2015).
Bueno de Oliveira T. et al. Prognostic impact and potential predictive role of baseline circulating tumor cells in locally advanced head and neck
squamous cell carcinoma. Oral Oncology 2021. DOI: https://doi.org/10.1016/j.oraloncology.2021.105480
DOWNLOAD »
Guedes de Castro D. et al. Prospective assessment of the association between circulating tumor cells and control of brain disease after focal radiotherapy of breast cancer brain metastases.
Advances in Radiation Oncology 2021. DOI: https://doi.org/10.1016/j.adro.2021.100673
DOWNLOAD »
Fanelli M.F. et al. Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor-beta receptor I in head and neck cancer. Head & neck 2017. DOI: https://doi.org/10.1002/hed.24899
DOWNLOAD »
Tariki M.S. et al. Circulating tumor cells as a predictor and prognostic tool for metastatic
clear cell renal carcinoma: An immunocytochemistry and genomic analysis. Pathology – Research and Practice 253 (2024) 154918.
DOWNLOAD »
Broncy L. et al. Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma. Oncotarget 9, 20058-20074 (2018).
DOWNLOAD »
Pignataro, B. S., et al. Is platelet-lymphocyte ratio (PLR) a predictor of thrombosis and together with circulating tumor cells capable to determine recurrence-free survival in patients with gastric cancer? Brazilian Journal of Oncology, 2022 DOI: 10.5935/2526-8732.20220350
DOWNLOAD »
Abdallah E.A. et al. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer. The oncologist 24, e854-e863 (2019).
DOWNLOAD »
Chinen L.T.D. et al. Circulating Polyploid Giant Cancer Cells, a Potential Prognostic Marker in Patients with Carcinoma. Int. J. Mol. Sci. 2024, 25, 9841. https://doi.org/ 10.3390/ijms25189841
DOWNLOAD »
Ali AM. et al. Circulating cancer giant cells with unique characteristics frequently found in patients with myelodysplastic syndromes (MDS). Med Oncol 40, 204 (2023). https://doi.org/10.1007/s12032-023-02064-z
DOWNLOAD »
Braun AC. et al. Circulating Tumor Cells in Desmoid Tumors: New Perspectives. Front. Oncol., 14 September 2021. DOI: https://doi.org/10.3389/fonc.2021.622626
DOWNLOAD »
Uguen A. Digital Pathology Slides-based Measurement of Tumor Cells and Lymphocytes Within Cytology Samples Supports the Relevance of the Separation by Size of Nonhematological Tumor and Hematological Nontumor Cells in Liquid Biopsies. Appl Immunohistochem Mol Morphol 2021;29:494–498. DOI: 10.1097/PAI.0000000000000931.
DOWNLOAD »
Laget S. et al. Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion. PLoS One 12, e0169427 (2017).
DOWNLOAD »
Pailler E. et al. Method for semi-automated microscopy of filtration-enriched circulating tumor cells. BMC Cancer 16, 477 (2016).
DOWNLOAD »
Farace F. et al. A Direct Comparison of CellSearchTM and ISET® for Circulating Tumour-Cell Detection in Patients with Metastatic Carcinomas. Br J Cancer 105, 847-853 (2011).
DOWNLOAD »
Eifler R.L. et al. Enrichment of Circulating Tumor Cells from a Large Blood Volume Using Leukapheresis and Elutriation: Proof of Concept. Cytometry B Clin Cytom 80, 100-111 (2011).
DOWNLOAD »
Vona G. et al. ISET, Isolation by Size of Epithelial Tumor cells: a new method for isolation, immuno-morphological and molecular characterization of circulating tumor cells. Am J Pathol 156, 57-63 (2000).
DOWNLOAD »
Benzaquen J. et al. Lung Cancer Screening, Towards a Multidimensional approach: why and how? Cancers (Basel) 11 (2019).
DOWNLOAD »
Broncy L. & Paterlini-Bréchot P. Circulating Tumor Cells for the Management of Renal Cell Carcinoma. Diagnostics (Basel, Switzerland) 8 (2018).
DOWNLOAD »
Hong Y. & Zhang Q. Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 37, 5663-5674 (2016).
DOWNLOAD »
Hofman V. et al. Detection and characterization of circulating tumor cells in lung cancer: Why and how? Cancer cytopathology 124, 380-387 (2016).
DOWNLOAD
Paterlini-Bréchot P. Circulating Tumor Cells: Who is the killer? Cancer Microenviron 7, 161-176 (2014).
DOWNLOAD »
Khoja L. et al. Circulating tumor cells as tumor biomarkers in melanoma: detection methods and clinical relevance. Ann Oncol 26, 33-39 (2015).
DOWNLOAD »
Hofman V. et al. Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy : promises, drawbacks and pitfalls. Curr Mol Med 14, 440-456 (2014).
DOWNLOAD »
Laget S. et al. Theranostic application of cytopathological detection of circulating tumor cells isolated by ISET® and of their molecular characterization (French). Corresp Onco-Theranostic Vol II n 4, 190-195 (2013).
DOWNLOAD »
Ma Y.C. et al. Recent Advances and Prospects in the Isolation by Size of Epithelial Tumor Cells (ISET) Methodology. Technol Cancer Res Treat 12, 295-309 (2013).
DOWNLOAD »
Paterlini-Bréchot P. Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy. Future Oncol 7, 849-871 (2011).
DOWNLOAD »
Descamps V. et al. ISET device: a useful tool to answer some questions about the biologic behavior of melanocytic nevus cells. Arch Dermatol 146, 1156-1157 (2010).
DOWNLOAD »
Paterlini-Bréchot P. & Benali N. Circulating Tumor Cells (CTC) detection: Clinical impact and future directions. Cancer Lett 253, 180-204 (2007).
DOWNLOAD »